These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21772829)

  • 1. Host Kinase Activity is Required for Coxiella burnetii Parasitophorous Vacuole Formation.
    Hussain SK; Broederdorf LJ; Sharma UM; Voth DE
    Front Microbiol; 2010; 1():137. PubMed ID: 21772829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages.
    Colonne PM; Winchell CG; Graham JG; Onyilagha FI; MacDonald LJ; Doeppler HR; Storz P; Kurten RC; Beare PA; Heinzen RA; Voth DE
    PLoS Pathog; 2016 Oct; 12(10):e1005915. PubMed ID: 27711191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages.
    MacDonald LJ; Kurten RC; Voth DE
    Infect Immun; 2012 Jun; 80(6):1980-6. PubMed ID: 22473604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncanonical Inhibition of mTORC1 by Coxiella burnetii Promotes Replication within a Phagolysosome-Like Vacuole.
    Larson CL; Sandoz KM; Cockrell DC; Heinzen RA
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Cholesterol in the
    Mulye M; Samanta D; Winfree S; Heinzen RA; Gilk SD
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246364
    [No Abstract]   [Full Text] [Related]  

  • 6. Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.
    Graham JG; MacDonald LJ; Hussain SK; Sharma UM; Kurten RC; Voth DE
    Cell Microbiol; 2013 Jun; 15(6):1012-25. PubMed ID: 23279051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2α Activity for Efficient Intracellular Replication.
    Brann KR; Fullerton MS; Voth DE
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32284364
    [No Abstract]   [Full Text] [Related]  

  • 8. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.
    Larson CL; Beare PA; Voth DE; Howe D; Cockrell DC; Bastidas RJ; Valdivia RH; Heinzen RA
    Infect Immun; 2015 Feb; 83(2):661-70. PubMed ID: 25422265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival.
    Macdonald LJ; Graham JG; Kurten RC; Voth DE
    Cell Microbiol; 2014 Jan; 16(1):146-59. PubMed ID: 24028560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Content Imaging Reveals Expansion of the Endosomal Compartment during
    Larson CL; Heinzen RA
    Front Cell Infect Microbiol; 2017; 7():48. PubMed ID: 28293541
    [No Abstract]   [Full Text] [Related]  

  • 11. Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes.
    Winchell CG; Graham JG; Kurten RC; Voth DE
    Infect Immun; 2014 Jun; 82(6):2229-38. PubMed ID: 24643534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionation of the Coxiella burnetii parasitophorous vacuole.
    Howe D; Heinzen RA
    Methods Mol Biol; 2008; 445():389-406. PubMed ID: 18425464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The secreted protein kinase CstK from
    Martinez E; Huc-Brandt S; Brelle S; Allombert J; Cantet F; Gannoun-Zaki L; Burette M; Martin M; Letourneur F; Bonazzi M; Molle V
    J Biol Chem; 2020 May; 295(21):7391-7403. PubMed ID: 32303638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity.
    Voth DE; Heinzen RA
    Infect Immun; 2009 Jan; 77(1):205-13. PubMed ID: 18981248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxiella burnetii Subverts p62/Sequestosome 1 and Activates Nrf2 Signaling in Human Macrophages.
    Winchell CG; Dragan AL; Brann KR; Onyilagha FI; Kurten RC; Voth DE
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483292
    [No Abstract]   [Full Text] [Related]  

  • 16. The Coxiella burnetii parasitophorous vacuole.
    Ghigo E; Colombo MI; Heinzen RA
    Adv Exp Med Biol; 2012; 984():141-69. PubMed ID: 22711631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.
    Beare PA; Gilk SD; Larson CL; Hill J; Stead CM; Omsland A; Cockrell DC; Howe D; Voth DE; Heinzen RA
    mBio; 2011; 2(4):e00175-11. PubMed ID: 21862628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxiella burnetii effector protein subverts clathrin-mediated vesicular trafficking for pathogen vacuole biogenesis.
    Larson CL; Beare PA; Howe D; Heinzen RA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4770-9. PubMed ID: 24248335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of the Coxiella burnetii parasitophorous vacuole requires bacterial protein synthesis but not replication.
    Howe D; Melnicáková J; Barák I; Heinzen RA
    Cell Microbiol; 2003 Jul; 5(7):469-80. PubMed ID: 12814437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusogenicity of the Coxiella burnetii parasitophorous vacuole.
    Howe D; Melnicákova J; Barák I; Heinzen RA
    Ann N Y Acad Sci; 2003 Jun; 990():556-62. PubMed ID: 12860689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.